Search bioRxivSearch

Biology subjects

Timonen, S.

Publications and source records attributed to Timonen, S..

2 recordsLinked to original sources

Improved detection of differentially represented DNA barcodes for high-throughput lineage phenomics

Cellular DNA barcoding has become a popular approach to study heterogeneity of cell populations and to identify lineages with differential response to cellular stimuli. However, there is a lack of reliable methods for statistical inference of differentially responding lineages. Here, we used mixtures of DNA-barcoded cell pools to generate a realistic benchmark read count dataset for modelling a range of outcomes of lineage-tracing experiments. By accounting for the statistical properties intrinsic to the DNA barcode read count data, we implemented an improved algorithm that provides a significantly higher accuracy at detecting differentially responding lineages, compared to current RNA-seq data analysis algorithms. Building on the reliable statistical methodology, we illustrate how multidimensional phenotypic profiling (or high-throughput lineage phenomics) enables one to deconvolute phenotypically distinct cell subpopulations within a cancer cell line. The mixture control dataset and our analysis results provide a systematic foundation for benchmarking and improving algorithms for lineage-tracing experiments.

bioinformatics

SynToxProfiler: an approach for top drug combination selection based on integrated profiling of synergy, toxicity and efficacy

Drug combinations are becoming a standard treatment of many complex diseases due to their capability to overcome resistance to monotherapy. Currently, in the preclinical drug combination screening, the top hits for further study are often selected based on synergy alone, without considering the combination efficacy and toxicity effects, even though these are critical determinants for the clinical success of a therapy. To promote the prioritization of drug combinations based on integrated analysis of synergy, efficacy and toxicity profiles, we implemented a web-based open-source tool, SynToxProfiler (Synergy-Toxicity-Profiler). When applied to 20 anti-cancer drug combinations tested both in healthy control and T-cell prolymphocytic leukemia (T-PLL) patient cells, as well as to 77 anti-viral drug pairs tested on Huh7 liver cell line with and without Ebola virus infection, SynToxProfiler was shown to prioritize synergistic drug pairs with higher selective efficacy (difference between efficacy and toxicity level) as top hits, which offers improved likelihood for clinical success.

bioinformatics